Dr. Mark M. Gajjar, MD

Dr. Gajjar practices at Ascension Seton Hays in Kyle, Texas, part of Ascension Health Alliance.

Dr. Gajjar's NPI, 1942519319, was assigned on October 1, 2010. Dr. Gajjar graduated from University of Illinois College of Medicine - Chicago in 2010. Dr. Gajjar holds Texas license R9755.

Dr. Gajjar's primary practice is Ascension Seton Hays, at 6001 Kyle Pkwy, Kyle, TX 78640 in Hays County. The practice phone is (512) 324-5000.

Dr. Gajjar's primary practice is Ascension Seton Hays in Kyle, Texas, part of Ascension Health Alliance. Dr. Gajjar is also affiliated with Ascension Seton Medical Center Austin. The medical group on file is Seton Family of Doctors. Dmand AI also links Dr. Gajjar to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gajjar practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Gajjar's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Gajjar is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Gajjar's licenses on file in 2 states: Texas and Illinois.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Gajjar treats.

CMS data shows 2,048 Medicare services from Dr. Gajjar across 30 procedure codes in 2024, for 517 Medicare patients. Medicare paid $165,684 for them.

CMS counts 517 Medicare patients who saw Dr. Gajjar in 2024. The largest group is 75 to 84, with 212 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gajjar's median patient age at 74, with 47% women.

In 2024, Dr. Gajjar wrote 3,653 Medicare Part D claims for 548 patients. 86% of them were for generic drugs. CMS names the drug for 3,449 of them, across 35 drugs with 11 or more claims each, at $467,688 in total drug cost. In 2023, CMS named 3,111 claims across 30 drugs.

Dr. Gajjar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gajjar as offering telehealth. CMS counts 38 procedures of coronary angioplasty and stenting by Dr. Gajjar, more than 74% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Gajjar, published from 2015 to 2019. 2015 was the busiest year, with 2. The most frequent topics are Heart Valve Prosthesis and Heart Valve Prosthesis Implantation. Dr. Gajjar's most frequent co-authors are Ajay Yadlapati, MD, S. Christopher Malaisrie, MD and Eric Page Cantey, MD.

Dmand AI links Dr. Gajjar to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Atherosclerosis, Foramen Ovale, Patent and Arteriosclerosis.

CMS Open Payments shows 419 general payments to Dr. Gajjar from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 49% of the total. Abbott Laboratories paid the most, $50,976.

Dr. Gajjar graduated from University of Illinois College of Medicine - Chicago in 2010.

Dr. Gajjar is in network with 23 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.